|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/16 | |
| A61K 31/165 | |||
| A61P 17/02 | |||
| A61P 29/00 |
| (11) | Number of the document | 3218059 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15858728.7 |
| Date of filing the European patent application | 2015-11-13 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/060670 |
| Date | 2015-11-13 |
| (87) | Number | WO 2016/077749 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462079121 P | 2014-11-13 | US |
| (72) |
CAMPBELL, James N., US
HANSON, Peter D., US
|
| (73) |
Centrexion Therapeutics Corporation,
509 South Exeter Street, Suite 202, Baltimore, MD 21202,
US
|
| (54) | CAPSAICINOIDS FOR USE IN TREATING ACRAL LICK GRANULOMA |
| CAPSAICINOIDS FOR USE IN TREATING ACRAL LICK GRANULOMA |